Journal: Cell death & disease
Article Title: IGF2BP2-meidated m 6 A modification of CSF2 reprograms MSC to promote gastric cancer progression.
doi: 10.1038/s41419-023-06163-7
Figure Lengend Snippet: Fig. 4 IGF2BP2 modulates CSF2 m6A modification to induce MSC reprogramming. A In vitro tropism of MSCs towards HGC-27 cells assessed via a transwell system. Original magnification: ×100. Scale bar = 50 μm. B, C qRT-PCR (B) and western blot (C) analyses of FAP and α- SMA expression in MSCs from different groups. D Luminex analyses of the inflammatory factor profile in the supernatants from MSCs. E, F The proliferation of HGC-27 cells following exposure to the supernatants from different MSCs was assessed by cell viability (E) and colony formation assays (F). G Transwell assay for the migration of HGC-27 cells upon treatment with the supernatants from different MSCs. Original magnification: ×100. Scale bar = 50 μm. H CCK-8 assay for IC50 of 5-FU in HGC-27 cells treated with the supernatants from different MSCs. I Flow cytometric analyses of the apoptotic rate of HGC-27 cells after exposure to 5-FU. *P < 0.05; **P < 0.01; ***P < 0.001.
Article Snippet: Primary antibodies against FAP (#66562), α-SMA (#19245), Notch1 (#3608), CSF2 (#56712), ubiquitin (#20326) (Cell Signaling Technology, USA), and IGF2BP2 (11601-1-AP, Proteintech, Wuhan, China) were applied to the membranes for incubation. β-actin (CW0096M, Cwbio, Beijing, China) was used as the loading control.
Techniques: In Vitro, Quantitative RT-PCR, Western Blot, Expressing, Luminex, Transwell Assay, Migration, CCK-8 Assay